Federal grants to Bolden Therapeutics Inc
Bolden Therapeutics Inc in Providence, Rhode Island received $2.3 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $2.3 million. In fiscal 2025 more was taken back from its awards than added, a net -$2,828.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.3 million
- Awards4
- Awarded in FY 2025-$2,828
- Largest award$896,442
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $500,000 |
| FY 2022 | 2 | $904,016 |
| FY 2023 | 1 | $396,914 |
| FY 2024 | 1 | $504,505 |
| FY 2025 | 0 | -$2,828 |
Programs that fund Bolden Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 4 | $2.3 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $2.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Promoting adult hippocampal neurogenesis in alzheimer's disease using an antibody-based therapy - project summary alzheimer's disease (AD) is a looming public health crisis that threatens millions of patients' ability to experience healthy aging. In addition to the challenges that ad poses to patien | Aging Research | September 13, 2021 | $896,442 |
| Preclinical characterization of splice-modifying antisense oligonucleotides targeting neurogenesis in human ad neural cells - project summary there is an enormous need for therapeutics to prevent and treat alzheimer’s disease (AD). Adult hippocampal neurogenesis (AHN) is critical for normal learning | Aging Research | July 31, 2024 | $504,505 |
| Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an alzheimer's disease therapy - project summary there is an enormous need for therapeutics to prevent and treat alzheimer's disease (AD). Adult hippocampal neurogenesis (AHN) is critical for normal learning and memory, but | Aging Research | June 14, 2022 | $496,952 |
| Entrepreneurial development award for a novel alzheimer's disease therapeutic - the aging population in the us and globally has led to an urgent need for therapeutics to prevent and treat alzheimer's disease (AD). Adult hippocampal neurogenesis (AHN) is critical for normal learning and memory and de | Aging Research | September 1, 2022 | $404,707 |
Questions people ask
How much federal grant money does Bolden Therapeutics Inc get?
$2.3 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Bolden Therapeutics Inc the most?
The Department of Health and Human Services, with $2.3 million in 4 awards.
What is Bolden Therapeutics Inc's largest federal grant?
$896,442 under Aging Research, with its first action in the period on September 13, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Providence
- State of Rhode Island Department of Administration
- Rhode Island Dot
- RI Department of Elementary and Secondary Education
- Brown University
- State of Rhode Island Department of Health
- Rhode Island Infrastructure Bank
- Rhode Island Public Transit Authority
- State of Rhode Island Office of Energy Resources
Largest federal grant recipients in Rhode Island · Federal grants in Rhode Island